CN and Unifor Affiliated CNTL Drivers Reach Tentative Agreement
January 17, 2024 07:30 ET
|
Canadian National Railway Company
MONTREAL, Jan. 17, 2024 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that CNTL, a CN subsidiary dedicated to first and last mile trucking container pickup and deliveries, has...
Venus Concept Launches Venus Prime
January 17, 2024 07:30 ET
|
Venus Concept Inc.
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announced today the launch of Venus...
GURU Organic Energy Adds New Peach Mango Punch to Its Punch Lineup in the US, Following the Recent Launch of Fruit Punch
January 17, 2024 07:30 ET
|
GURU Organic Energy Corp.
Peach Mango Punch offers an amazing flavor explosion, with GURU’s unique blend of natural ingredients to increase focus and brain performance.Newest addition to punch line, Peach...
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
January 17, 2024 07:30 ET
|
DiagnaMed Holdings Corp.
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health artificial intelligence company focused on brain...
HydroGraph Releases CEO Letter to Shareholders
January 17, 2024 07:30 ET
|
Hydrograph Clean Power Inc.
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- HydroGraph Clean Power Inc. (CSE: HG) (OTCBQ: HGCPF) (the “Company” or “HydroGraph”), a manufacturer of pristine graphene, today issued the following...
Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea
January 17, 2024 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia and NEW YORK, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing unique...
Glycobiology Market Is Projected to Value US$ 5,435.4 million by 2034: Fact.MR Report
January 17, 2024 07:30 ET
|
FACT.MR
Rockville , Jan. 17, 2024 (GLOBE NEWSWIRE) -- The global glycobiology market size is projected to reach US$ 1,670.3 million in 2024. The sales of glycobiology are expected to witness a robust CAGR...
Thioglycolate Market: Catalyzing Growth with a Target Valuation of US$ 364.3 Million and a Dynamic CAGR of 10% by 2034 | Future Market Insights, Inc.
January 17, 2024 07:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The Thioglycolate market is estimated to be valued at US$ 152.7 million in 2024. The market is anticipated to reach US$ 364.3 million by 2034. Players...
Veeco Updates Fourth Quarter 2023 Guidance and Provides Initial 2024 Outlook
January 17, 2024 07:30 ET
|
Veeco Instruments Inc.
Updates fourth quarter revenue guidance to $165 to $175 million & Non-GAAP diluted EPS between $0.40 to $0.45 centsInitial 2024 revenue outlook of $680 to $740 million & Non-GAAP diluted EPS...
Patient Engagement Solutions Market is Expected to Reach $41.8 Billion | MarketsandMarkets™
January 17, 2024 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Patient Engagement Solutions market in terms of revenue was estimated to be worth $41.8 Billion in 2023 and is poised to reach $41.8 Billion by 2028,...
- May 03, 2024 19:15 ET GDRX Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against GoodRx Holdings, Inc.
- May 03, 2024 19:13 ET ADSK Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against Autodesk, Inc.